4//SEC Filing
Foundation Medicine, Inc. 4
Accession 0001209191-14-045132
CIK 0001488613operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:06 PM ET
Size
7.8 KB
Accession
0001209191-14-045132
Insider Transaction Report
Form 4
KRENITSKY KEVIN
Chief Commercial Officer & SVP
Transactions
- Other
Common Stock
2014-06-30+203→ 140,750 total - Sale
Common Stock
2014-07-01$27.20/sh−69$1,877→ 140,681 total
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on April 9, 2014.
- [F2]The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014. As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect this vesting event.
- [F3]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F4]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.1500 to $27.2261, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488613
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:06 PM ET
- Size
- 7.8 KB